Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

NCT00406068 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Neoplasms

Interventions

DRUG: Mycobacterial cell wall-DNA complex

Sponsor

Bioniche Life Sciences Inc.